Faculty Directory

Office of the Dean Administration Departments Research Alpert Medical School Public Health Program Giving

J. Dawn Abbott, MD

Edit My Page
J. Dawn Abbott

Title: Assistant Professor
Department: Medicine

Jinnette_Dawn_Abbott@brown.edu
+1 401 444 8540

 
Overview | Grants/Awards | Publications

Biography

Dr. J. Dawn Abbott is an interventional cardiologist in the Division of Cardiology at Rhode Island Hospital. She is an attending physician in the coronary care unit. Her clinical and research interests involve percutaneous coronary and peripheral interventions. She studies the importance of several factors such as demographic and angiographic characteristics on outcomes in percutaneous interventions as well as the clinical utility of platelet function testing in patients with coronary artery disease.

Institutions

RIH

Affiliations

Fellow of the American College of Cardiology
American Heart Association, Member of the Council on Cardiovascular Radiology and Intervention

Funded Research

Grant Support American College of Cardiology Foundation (ACCF) Career Development Award in Acute Coronary Syndromes (07/05-06/06)

The determination of non-responsiveness to anti-platelet therapy in patients undergoing percutaneous coronary intervention using a point of care device, The Rhode Island Foundation: Medical Research Grant (2/07-1/08)

Selected Publications

  • Marroquin OC, Selzer F, Mulukutla SR, Williams DO, Vlachos HA, Wilensky RL, Tanguay JF, Holper EM, Abbott JD, Lee JS, Smith C, Anderson WD, Kelsey SF, Kip KE. A Comparison of Bare Metal and Drug-Eluting Stents for Off-Label Indications: Findings from The NHLBI Dynamic Registry. N Engl J Med, 2008; 358: 342-352.(2008)
  • Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, Laskey W, Williams DO, Smith C., Anderson WD, MD; Lee JS, Srinivas V, Kelsey SF, Kip KE. Drug-Eluting Stents Have Attenuated Benefit Among Insulin-Treated Diabetic Patients A Report from the NHLBI Dynamic Registry. J Am Coll Cardiol: CI, 2008;1;139-147.(2008)
  • Abbott JD, Voss MR, Nakamura M, Cohen HA, Selzer F, Kip KE, Vlachos HA, Wilensky RL, Williams DO. Unrestricted Use of Drug Eluting Stents Compared to Bare Metal Stents in Routine Clinical Practice: Findings from the NHLBI Dynamic Registry. J Am Coll Cardiol 2007;50, 2029-2036.(2007)
  • Abbott JD, Sharaf BL, Vlachos H, Selzer F, Holper E, Glaser R, Jacobs A, and Williams DO. Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) Am J Cardiol 2007; 99:626-631.(2007)
  • Abbott JD, Ahmed HN, Vlachos HA, Selzer F, and Williams DO. Comparison of Outcome in Patients with ST-Elevation-vs-Non ST-Elevation Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention (From the National Heart, Lung, and Blood Institute Dynamic Registry) Am J Cardiol 2007;100:190-195.(2007)
  • Freeman AM, Abbott JD, Jacobs AK, Vlachos HA, Selzer F, Detre KM, and Williams, DO. Marked Improvements in In-Hospital and One Year Outcomes Following Contemporary PCI in Patients with Diabetes Mellitus. J Interv Cardiol 2006, 19:475-482.(2006)
  • Glaser R, Selzer, F, Jacobs, AJ, Laskey WK, Kelsey SF, Holper LM, Cohen HA, Abbott JD and Wilensky RL. Effect of Gender on Prognosis following Percutaneous Coronary Intervention for Stable Angina Pectoris and Acute Coronary Syndromes, Am J Cardiol 2006; 98:1446-50.(2006)
  • Williams DO, Abbott JD, Kip KE, and the DEScover Investigators. Outcomes of 6,906 Patients Undergoing Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents: Report of the DEScover Registry. Circulation,114:2154-2162, 2006.(2006)
  • Abbott JD, Kip KE, Vlachos HA, Sawhney N, Srinivas VS, Jacobs AK, Holmes DR, and Williams DO. Lack of Recent Improvement in the Percutaneous Treatment of Chronic Total Coronary Occlusions. Am J Cardiol, 97(12):1691-96, 2006.(2006)
  • Abbott JD, Choi EJ, Selzer F, Srinivas VS, and Williams DO. Impact of Coronary Collaterals on Outcome Following Percutaneous Coronary Intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol, 96(5);676-80, 2005.(2005)
  • Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, and Giordano FG. SDF-1 Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but is not Sufficient to Induce Homing in the Absence of Injury, Circulation,110:3300 – 3305, 2004.(2004)